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The work described here began as a project
to use differential hybridization to identify
genes that were induced after T cell activa-
tion. In reality, it became something com-
pletely different when the approach iden-
tified genes that encoded proteins involved
in the killing mechanism used by T lym-
phocytes (1, 2).
The late 1970s and early 1980s were
exciting times of discovery in immunology.
Lots of fascinating biological observations
had already been made but there was lit-
tle in the way of molecular understanding.
During this period, the newly emerging
tools of recombinant DNA technology and
molecular biology were becoming more
readily accessible and being applied to
study immunological questions. This led to
many exciting discoveries such as antibody
and T cell receptor gene rearrangements
(3–5).
I had some experience looking at anti-
body genes and the biochemical and
genetic characterization of interleukin 2.
Using these new approaches, I decided to
investigate cytotoxic T cell (CTL) activa-
tion at the level of gene activation. The
guiding hypothesis was that the pheno-
type of a cell was governed by the proteins
expressed. We posited that each cell would
express a set of function related proteins
and their corresponding mRNAs. Conse-
quently, we set about to identify mRNAs
that were expressed specifically in acti-
vated CTL. At worst, we believed that this
approach would uncover a set of interest-
ing genes to study CTL activation at the
transcriptional level. The real hope was that
we would identify proteins involved in the
killing mechanism. Interestingly, when this
was reviewed for funding it was described
as a fishing expedition. These days that
would be the kiss of death for a proposal.
However, these were more reasonable times
and it was funded.
At the time, very little was known about
how CTL induced death in target cells that
they recognized. The effector cells were
known to contain cytoplasmic granules
that polarized toward the target upon con-
jugate formation. It was believed that they
contained cytolytic proteins that induced
membrane damage. One of the key mol-
ecules responsible for the ring-like lesion
observed on target cells was ultimately
shown to be cytolysin/perforin (6, 7).
We took advantage of the discovery of
methods for the long term culture of CTL
(8) and had generated a CTL line MTL2.8.2
(9). Using mRNA from this killer cell, a
library of 4000 cDNA clones were gener-
ated. Individual colonies were picked and
isolated in microtiter plates. Copies of these
were replicated in triplicate onto nitrocel-
lulose and grown. After lysis, the blots were
hybridized with 32-P cDNA probe gen-
erated from MTL poly A+ RNA. Positive
colonies were identified and then the three
copies of the library on the membrane were
stripped and re-probed with radioactive
cDNA prepared from a helper T cell line
CH1. After autoradiography, the blots were
again stripped and hybridized with probe
from unactivated thymocytes.
The various autoradiograms were com-
pared. Only colonies, which were strongly
positive in two copies with the MTL probe
and negative with CH1 and thymocyte
cDNA, were selected. That gave us 121,
which were rescreened yielding 36, which
were clearly CTL specific. Two were cho-
sen for further analysis; B10 was the most
abundant and cross hybridized with eight
other inserts and C11 because it was related
to B10 but different. Tissue specificity
cytodots clearly established that these two
were CTL specific. The one exception was
a signal in a suppressor T cell line derived
from fetal thymus (10). This was not pur-
sued further as the suppressor field was
murky at best at this time. However, now
it seems likely that this was a regulatory
T cell.
The key observation was the correlation
of mRNA expression of both B10 and C11
with cytotoxicity in both allogeneic and
mitogen stimulated spleen cells. The level
of killing measured in a chromium release
assay peaked roughly 24 h after the maxi-
mum levels of both B10 and C11. In addi-
tion, as cytotoxicity declined, so did expres-
sion of the mRNAs (1). This was exactly
the behavior expected for function related
transcripts when it became very exciting.
A full length clone for C11 was isolated
and sequenced. An open reading frame was
identified, which predicted that the protein
encoded was a serine proteinase most sim-
ilar to the rat mast cell proteinases. Most
important, the predicted protein contained
the catalytic triad responsible for the enzy-
matic activity of this family of enzymes.
A full length clone corresponding to B10
could not be found but sequence homol-
ogy and sequence alignment predicted that
it also encoded a proteinase.
At this time, I met Irv Weissman
at a conference and discovered that his
group had also cloned a serine proteinase
gene from activated CTL. Sequences were
compared and much to our delight that
they were related but different. It was
decided that the two manuscripts would
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be submitted together to Science. Rather
surprisingly, Irv’s paper was accepted but
ours was rejected. Only through Irv’s direct
intervention with the editor was this deci-
sion reversed and the two papers appeared
side-by-side (2, 11).
They named their enzyme Hanukkah
Factor while ours were christened cytotoxic
cell proteinase 1 and 2 (CCP). Follow-
ing the outstanding biochemical purifica-
tion of a family of serine proteinases from
CTL granule by Jurg Tschopp’s group, they
became more commonly called granzymes
(12). Granzyme B (CCP1) was also named
CTLA1 by Pierre Goldstein’s group (13).
The majority of these genes are clustered
on mouse chromosome 14 close to the
alpha-chain of the TCR (14).
The discovery of these enzymes cre-
ated quite a stir of excitement in the field.
Hudig and Redelman had suggested, for
many years, a key role for proteinases in
the killing mechanism. Pasternack et al.
had recently demonstrated the importance
of a trypsin-like enzyme that was asso-
ciated with perforin containing granules
and secreted upon target cell interaction
(15). In addition, the groups of Podack
and Henkart had purified the proteins
responsible for the ring-like lesions seen
in membranes treated with cytolytic gran-
ules. They named the molecules perforin
(6) and cytolysin (7), but later it became
apparent that they were the same protein.
The general consensus was that the killing
mechanism involved a proteinase cascade
analogous to that seen in the complement
system. The ultimate target of this cascade
model was perforin, which upon activa-
tion would create the membrane damage
observed.
We now know that perforin mediated
target cell lysis is not the whole story.
Rather cells under attack by CTL die via
a mechanism involving DNA fragmenta-
tion. Perforin alone cannot mediate this
form of death. It is now known that per-
forin facilitates the uptake and release of
granzymes into the cytoplasm of the tar-
gets. The granzymes then cleave specific
substrates that bring about the ultimate
demise of the cell. Most notable is the
cleavage of caspases by granzyme B that
initiates apoptosis and brings about DNA
fragmentation, but it took another 10 years
to discover this (16, 17).
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